• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC | Inspections

New Search Back to Search Results
Note: this medical device record is a supplement. The device description may have changed. Be sure to look at the original PMA to get an up-to-date view of this device.
Classification Nameaortic valve, prosthesis, percutaneously delivered
PMA NumberP130021
Supplement NumberS014
Date Received04/23/2015
Decision Date06/22/2015
Product Code
NPT[ Registered Establishments with NPT ]
Advisory Committee Cardiovascular
Clinical Trials NCT02207569
Supplement Typenormal 180 day track
Supplement Reason change design/components/specifications - component
Expedited Review Granted? No
Combination Product No
Approval Order Statement 
Approval for a design iteration of the 23, 26, and 29 mm medtronic corevalve system. The new components include corevalve evolut r transcatheter aortic valves, models evolutr-23-us, evolutr-26-us, and evolutr-29-us, enveo r delivery catheter system, model enveor-us, and enveo r loading systems, models ls-enveor-23us and ls-enveor-2629us. These components will be marketed under the trade name corevalve evolut r system.